Standout Papers

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without ... 2019 2026 2021 2023 333
  1. Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer (2019)
    Jeffrey D. Bradley, Chen Hu et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 63 standout
Sub-graph 1 of 25

Citing Papers

A new era of cancer phototherapy: mechanisms and applications
2024 Standout
The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy
2023 Standout
2 intermediate papers

Works of Christopher D. Koprowski being referenced

Multicenter Phase Ib/II Trial of the Radiation Enhancer Motexafin Gadolinium in Patients With Brain Metastases
2001

Author Peers

Author Last Decade Papers Cites
Christopher D. Koprowski 689 345 309 29 1.1k
Anthony T. Pu 587 260 459 19 950
Henrik Hauswald 530 215 323 55 1.0k
Domenico Cante 451 135 530 48 912
Kyle Wang 714 300 352 49 1.3k
Najeeb Mohideen 1023 373 355 36 1.4k
R. L. Scotte Doggett 854 291 238 26 1.3k
Dirk Boehmer 672 137 505 41 998
Marianne Marquard Knap 561 190 462 56 926
Ramona Mayer 647 168 274 20 996
Bernd Gagel 890 108 563 45 1.3k

All Works

Loading papers...

Rankless by CCL
2026